I help biotechs successfully conduct FDA-compliant trials, saving them 70% on costs 💊 ▸ High-Quality Research ▸ Up to 43.5% Aus R&D Grant ▸ No IND needed ▸ 8 Weeks Avg Startup ▸ FDA Expertise
As the #BIO2024 Conference approaches, iNGENū CRO is here to support companies navigating the complex landscape of biotech innovation and regulatory compliance. 🔬 Why partner with iNGENū? Cost Efficiency: Our unique business model reduces clinical trial costs by up to 70%, democratizing access to high-quality research. Regulatory Expertise: We offer comprehensive support for FDA, EMA, TGA, and MHRA regulatory requirements, ensuring your projects advance smoothly and swiftly. The Australian Advantage: Leveraging fast track regulatory processes and significant R&D tax incentives in Australia, we provide a strategic advantage in bringing products to trial faster and more cost-effectively. Even if you're not at BIO2024 and looking to explore new strategic partnerships or need advice on navigating FDA-centric clinical trials, we're here to help you achieve your research goals with our full suite of services from Phase 1 to Phase 3 trials. Reach out to learn more about how our innovative approaches can tailor support for your needs during and beyond BIO2024. #Biotechnology #ClinicalTrials
